To include your compound in the COVID-19 Resource Center, submit it here.

Epix Medical, Schering deal

The companies partnered to develop targeted contrast agents for use in MRI. EPIX will receive $4

Read the full 165 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE